Diethylstilboestrol and diethylstilboestrol dipropionate
- PMID: 397181
Diethylstilboestrol and diethylstilboestrol dipropionate
Abstract
PIP: This monograph on diethylstilbestrol (DES) and its dipropionate includes chemical and physical data (synonyms and trade names), structural and molecular formulae and molecular weight of DES, chemical and physical properties of DES, and the production, use, occurrence, and analysis of DES. Production of DES, which is not known to occur naturally, can be effected by using the following starting materials in its preparation: deoxyanisoin, para-anisaldehyde, anisole, or anethole hydrobromide. All known methods of analyzing the purity of DES are provided tabularly. DES has been used in human medicine for treating menopausal symptoms, as a postcoital emergency contraceptive, for prevention of postpartum breast engorgement, for chemotherapy of advanced carcinoma of the breast and prostate, and for treating dysfunctional uterine bleeding. It also has various veterinary uses, mainly as growth promoter in poultry and beef cattle. Although DES and its dipropionate do not occur naturally, humans are exposed to the agent occupationally, via food residues, and in water sources. Biological data relevant to the evaluation of carcinogenic risk to humans are also presented in brief. Experimental data include studies of various species and administration routes. In mice, DES exposure produced increased incidence of mammary and lymphoid tumors in both sexes; in rats, DES exposure raised incidences of pituitary, mammary, and bladder tumors. In hamsters, renal tumors had higher incidences after DES exposure: hamster offspring also showed tumors occurring in accessory sex organs. It is concluded that sufficient evidence exists for DES's carcinogenicity in experimental animals. DES is causally related to cancer occurring in humans, especially for human female offspring where a risk on the order of .14-1.4/1000 exposed daughters of vaginal or cervical clear cell adenocarcinoma was found.
Similar articles
-
Norethynodrel.IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:461-77. IARC Monogr Eval Carcinog Risk Chem Hum. 1979. PMID: 120839 Review.
-
Mestranol.IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:257-78. IARC Monogr Eval Carcinog Risk Chem Hum. 1979. PMID: 120834 Review.
-
Ethinyloestradiol.IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:233-55. IARC Monogr Eval Carcinog Risk Chem Hum. 1979. PMID: 120833 Review.
-
Medroxyprogesterone acetate.IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:417-29. IARC Monogr Eval Carcinog Risk Chem Hum. 1979. PMID: 120837
-
Norethisterone and norethisterone acetate.IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:441-60. IARC Monogr Eval Carcinog Risk Chem Hum. 1979. PMID: 120838 Review.
Cited by
-
Association Between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children.JAMA. 2022 Jan 4;327(1):59-66. doi: 10.1001/jama.2021.22482. JAMA. 2022. PMID: 34982120 Free PMC article.
-
Survey of tumorigenic sensitivity in 6-month rasH2-Tg mice studies compared with 2-year rodent assays.J Toxicol Pathol. 2022 Jan;35(1):53-73. doi: 10.1293/tox.2021-0031. Epub 2021 Nov 1. J Toxicol Pathol. 2022. PMID: 35221496 Free PMC article.
-
Enhancing potential of 6 different carcinogens on multi-organ tumorigenesis after initial treatment with N-methyl-N-nitrosourea in rats.Jpn J Cancer Res. 1991 Dec;82(12):1397-405. doi: 10.1111/j.1349-7006.1991.tb01812.x. Jpn J Cancer Res. 1991. PMID: 1778764 Free PMC article.
-
Environmental factors, epigenetics, and developmental origin of reproductive disorders.Reprod Toxicol. 2017 Mar;68:85-104. doi: 10.1016/j.reprotox.2016.07.011. Epub 2016 Jul 12. Reprod Toxicol. 2017. PMID: 27421580 Free PMC article. Review.